Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 6
1993 2
1994 4
1996 3
1997 1
1998 1
1999 1
2000 1
2002 1
2004 4
2005 1
2006 2
2007 3
2008 1
2009 1
2010 7
2011 4
2012 5
2013 5
2014 3
2015 2
2016 1
2020 1
2021 6
2022 3
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Targeting TSLP in Asthma.
Parnes JR, Molfino NA, Colice G, Martin U, Corren J, Menzies-Gow A. Parnes JR, et al. Among authors: molfino na. J Asthma Allergy. 2022 Jun 3;15:749-765. doi: 10.2147/JAA.S275039. eCollection 2022. J Asthma Allergy. 2022. PMID: 35685846 Free PMC article. Review.
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial.
Diver S, Khalfaoui L, Emson C, Wenzel SE, Menzies-Gow A, Wechsler ME, Johnston J, Molfino N, Parnes JR, Megally A, Colice G, Brightling CE; CASCADE study investigators. Diver S, et al. Among authors: molfino n. Lancet Respir Med. 2021 Nov;9(11):1299-1312. doi: 10.1016/S2213-2600(21)00226-5. Epub 2021 Jul 10. Lancet Respir Med. 2021. PMID: 34256031 Clinical Trial.
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials.
Corren J, Menzies-Gow A, Chupp G, Israel E, Korn S, Cook B, Ambrose CS, Hellqvist Å, Roseti SL, Molfino NA, Llanos JP, Martin N, Bowen K, Griffiths JM, Parnes JR, Colice G. Corren J, et al. Among authors: molfino na. Am J Respir Crit Care Med. 2023 Jul 1;208(1):13-24. doi: 10.1164/rccm.202210-2005OC. Am J Respir Crit Care Med. 2023. PMID: 37015033 Clinical Trial.
Near-fatal asthma.
Molfino NA, Slutsky AS. Molfino NA, et al. Eur Respir J. 1994 May;7(5):981-90. Eur Respir J. 1994. PMID: 8050557 Free article. Review.
Reply to Lipworth and Chan.
Ambrose CS, Israel E, Bowen K, Llanos JP, Martin N, Cook B, Hellqvist Å, Korn S, Menzies-Gow A, Roseti SL, Molfino NA, Griffiths JM, Parnes JR. Ambrose CS, et al. Among authors: molfino na. Am J Respir Crit Care Med. 2023 Jul 15;208(2):212-213. doi: 10.1164/rccm.202305-0843LE. Am J Respir Crit Care Med. 2023. PMID: 37279366 Free PMC article. No abstract available.
Genetics of COPD.
Molfino NA. Molfino NA. Chest. 2004 May;125(5):1929-40. doi: 10.1378/chest.125.5.1929. Chest. 2004. PMID: 15136409 Review.
Targeting of eosinophils in asthma.
Molfino NA. Molfino NA. Expert Opin Biol Ther. 2012 Jul;12(7):807-9. doi: 10.1517/14712598.2012.674938. Epub 2012 Apr 16. Expert Opin Biol Ther. 2012. PMID: 22500988
[Lung function evolution and respiratory symptoms].
Molfino NA. Molfino NA. Arch Bronconeumol. 2004 Oct;40(10):429-30. doi: 10.1016/s1579-2129(06)60350-9. Arch Bronconeumol. 2004. PMID: 15491532 Spanish. No abstract available.
68 results